1. Introduction {#s0005}
===============

Scale-free brain activity ([@bb0210]) has been examined and modeled on many levels, from neurotransmitter release ([@bb0400]), neuronal spiking ([@bb0315], [@bb0515]) and local field potentials ([@bb0040]), slow cortical potentials ([@bb0215]), and electroencephalography ([@bb0180]), suggesting the importance in examining the power-law property (e.g., not restricted to a particular temporal frequency/scale) of neural signals across multiple scales. Recent research suggests complexity measures of cerebral blood oxygenation level dependent (BOLD) signals as an important neural marker of cerebral activity dynamics ([@bb0005], [@bb0030], [@bb0085], [@bb0220]). Deviations from the typical range of power-exponents in BOLD time series have been noted in neuropsychiatric disorders ([@bb0305], [@bb0435], [@bb0455], [@bb0490], [@bb0545]). For instance, male adults with an autism spectrum condition showed a significant shift to randomness in endogenous brain oscillations, as compared to neurotypical individuals, in brain regions implicated in autism ([@bb0305]). Our previous studies of power spectrum scale invariance (PSSI) as a measure of nonlinear complexity demonstrated that as the neural circuits become increasingly dysregulated, signal complexity of affected nodes deviates from an equilibrium value, as observed in trait anxiety, epilepsy and schizophrenia ([@bb0455], [@bb0460], [@bb0490], [@bb0545]).

This intriguing scale-free property of brain activity is noted for more than a decade for fMRI signals ([@bb0065]). Although initially it was treated as a fractal noise, recent studies have shown that scale-free brain activity is not structured noise but rather is associated with rich temporal structures and functional significance ([@bb0085], [@bb0125], [@bb0175], [@bb0205], [@bb0220]). For instance, in an fMRI study, the power-law exponent decreased during performance of a visual detection task as compared to resting state ([@bb0205]). The power-law exponents presented distinct variation across functional brain networks, being larger for default-mode, saliency and visual networks ([@bb0175], [@bb0205]). Further, this increase in power-law exponents was correlated with glucose metabolism ([@bb0205]). These observations rule out the possibility that scale-free property of brain activity is simply noise. It was also reported that power-law exponents were correlated with fMRI signal variance across different brain regions, thus providing unique information complementing univariate and multivariate mean-based fMRI analyses ([@bb0205]). In fact, recent studies reported altered fMRI signal variance in task-induced activations ([@bb0050], [@bb0170]), highlighting the association between brain activity and second order statistics. Finally, it was also observed that complexity of low-frequency BOLD signals covaries with local connectivity ([@bb0005]). This relationship persisted even after regressing out the gray matter density and its standard deviation of the BOLD signal, suggesting that local interconnectivity may play a key role in establishing the complexity of low-frequency fluctuations. Thus, PSSI as a neural measure may capture an additional dimension of brain activity and connectivity that is not available from conventional analyses.

Chronic cocaine exposure is known to influence cerebral structures and functions, as highlighted by magnetic resonance imaging (MRI). For instance, functional MRI described altered regional activations in chronic cocaine users and individuals with prenatal exposure to drugs of abuse during a variety of behavioral challenges ([@bb0110], [@bb0185], [@bb0335], [@bb0440], [@bb0445], [@bb0450], [@bb0500]). In particular, frontal cortical regions including the dorsolateral prefrontal and anterior cingulate cortices have consistently been implicated in deficits of decision making in association with cocaine misuse ([@bb0100], [@bb0240], [@bb0235], [@bb0415]). Furthermore, recent work showed altered functional and effective connectivity of prefrontal, cingulate and subcortical structures during cognitive challenges in cocaine abusers ([@bb0080], [@bb0430], [@bb0600]). Together, these studies suggest the utility of fMRI to delineate the dysregulated neurocircuitry of cocaine addiction ([@bb0300]). However, it remains to be established how different components/nodes of the dysregulated circuit can be localized and quantified in terms of their dynamics. Conventional mean-based activation analyses do not necessarily identify regions where power spectrum and complexity properties are altered as a consequence of changes in interregional dynamic interactions.

Cocaine addiction is known to involve deficits in cognitive control ([@bb0135], [@bb0185], [@bb0190]). Dysfunctional error-related processes not only characterize cocaine addiction but also predict relapse in a longitudinal setting ([@bb0420]). In our previous work, we have employed a stop signal task (SST) to describe how participants respond trial by trial in anticipation of a stop signal ([@bb9000], [@bb9005]). While healthy individuals respond to stop signals by slowing down, cocaine addicts tend to be deficient in post-signal slowing, suggesting an impairment in signal monitoring and cognitive control ([@bb0165], [@bb0275], [@bb0270], [@bb0360], [@bb0340], [@bb0345], [@bb0375]). Here, we hypothesize that dysfunctional cognitive control in cocaine abusers can be characterized by altered power-exponent property of the underlying cerebral hemodynamics.

Considering that PSSI, along with other power-exponent measures, is closely associated with brain activity ([@bb0085], [@bb0090], [@bb0205], [@bb0220]) and has been used to describe circuit-level changes in fMRI signals ([@bb0455], [@bb0460], [@bb0485], [@bb0490], [@bb0545]), we took the logical step to examine differences in PSSI between cocaine dependent individuals and healthy controls and explore whether the differences in this dynamics marker are related to impaired post-signal slowing in cocaine addicts.

2. Material and methods {#s0010}
=======================

2.1. Subjects, informed consent, and assessment {#s0015}
-----------------------------------------------

Seventy-five patients (50 men) with cocaine dependence (CD) and eighty-eight age and gender matched healthy control (HC) subjects (49 men) participated in this study ([Table 1](#t0005){ref-type="table"}). CD participants were recruited from the local, greater New Haven area via newspapers and flyers as part of a prospective study ([@bb0420]) and met criteria for current cocaine dependence, as diagnosed by the Structured Clinical Interview for DSM-IV ([@bb0160]). Of the 84 CD participants examined in our previous morphometry study ([@bb0280]), 9 oldest subjects were excluded in order to match HC in age and gender. Thus, the subjects represented a convenience sample as no power calculation was performed to predetermine the sample size. Recent cocaine use was confirmed by urine toxicology screens upon admission. They were drug-free while staying in an inpatient treatment unit at the Connecticut Mental Health Center during the study period. All subjects were physically healthy with no major medical illnesses or current use of prescription medications. None of them reported having a history of head injury or neurological illness. Other exclusion criteria included dependence on other psychoactive substances (except nicotine) and current or past history of psychotic disorders. Individuals with current depressive or anxiety symptoms requiring treatment or currently being treated for these symptoms were excluded as well. The Human Investigation committee at Yale University School of Medicine approved the study, and all subjects signed an informed consent prior to participation.

All CD participants were assessed with the Beck Depression Inventory ([@bb0035]) and the State-Trait Anxiety Inventory ([@bb0520]) at admission, both with scores within the range reported previously for individuals with cocaine dependence ([@bb0145], [@bb0290], [@bb0395], [@bb0510]) ([Table 1](#t0005){ref-type="table"}). Cocaine craving was assessed with the Cocaine Craving Questionnaire, brief version (CCQ-Brief), for all participants on the same day of the fMRI ([@bb0525]). The CCQ-Brief is a 10-item questionnaire, abbreviated from the CCQ---Now ([@bb0540]). It is highly correlated with the CCQ---Now and other cocaine craving measures ([@bb0525]). Each item was rated on a scale from 1 to 7, with a higher total score (ranging from 10 to 70) indicating greater craving ([Table 1](#t0005){ref-type="table"}).

Healthy control participants (HC) were drawn from the local community, underwent a thorough interview by a psychiatrist (C.-S. R. Li) to rule out a DSM-IV diagnosis including abuse of or dependence on a substance other than nicotine, and all tested negative for illicit substances on the day of imaging. Smoking status and use of alcohol was documented. Previous use of any illicit substances and marijuana for longer than one year were exclusion criteria. As none of the HC reported depression or anxiety symptoms, HC were not assessed with the BDI or STAI. None of the HC were under any psychotropic medications during the year prior to the current study.

2.2. Behavioral task {#s0020}
--------------------

We employed a simple reaction time task in this stop-signal paradigm ([@bb0150], [@bb0230], [@bb0255], [@bb0270], [@bb0360], [@bb0365], [@bb0390], [@bb0575]). There are two trial types: "go" and "stop," presented with an inter-trial interval of 2 s, and occurring on each trial with 0.75 probability of being a go trial (0.25 probability stop trial). A small dot appears on the screen to engage attention at the beginning of a go trial. After a randomized time interval (fore-period) between 1 and 5 s, drawn from a uniform distribution, the dot turns into a circle (the "go" signal), prompting the subjects to quickly press a button. The circle vanishes at a button press or after 1 s has elapsed, whichever coming first, and the trial terminates. A premature button press prior to the appearance of the circle also terminates the trial. On a stop trial, an additional "X," the "stop" signal, appears after and replaces the go signal, and instructs participants to withhold their response. Similar to go trials, a stop trial terminates at button press or 1 s after the appearance of the stop signal. Failure to withhold the go response for the 1 s constitutes a stop error. The stop signal delay (SSD) -- the time interval between go and stop signals -- starts at 200 ms and is adjusted according to a staircase procedure, increasing and decreasing by 67 ms each for a successful and failed stop ([@bb0320]). Subjects were instructed to respond to the go signal quickly while keeping in mind that a stop signal could come up occasionally. The staircase procedure ensures that subjects would succeed in withholding their response in approximately half of the stop trials.

2.3. Analyses of behavioral performance in the stop signal task {#s0025}
---------------------------------------------------------------

We computed a critical SSD that represents the time delay between go and stop signals that a subject would need to succeed in 50% of the stop trials ([@bb0320]). Specifically, SSDs across trials were grouped into runs, with each run defined as a monotonically increasing or decreasing series. We derived a mid-run estimate by taking the middle SSD (or average of the two middle SSDs when there was an even number of SSDs) of every second run. The critical SSD was computed by taking the mean of all mid-run SSDs. It was reported that, except for experiments with a small number of trials (\< 30), the mid-run estimate was close to the maximum likelihood estimate of X~50~ (50% positive response; i.e., 50% SS in the SST, ([@bb0565])). The stop signal reaction time (SSRT) was computed by subtracting the critical SSD from the median go trial RT ([@bb0385]).

It is known that in the SST the RT of a correct response is prolonged following a stop signal, compared with other correct responses, and this prolonged RT is thought to reflect conflict monitoring. We thus computed the RT difference between the go trials that followed a stop trial and those that followed another go trial, and termed the effect size of this RT difference "post-signal slowing" (PSS) ([@bb0380]).

2.4. Image acquisition, preprocessing and statistical tests {#s0030}
-----------------------------------------------------------

All imaging data were collected in the same 3T Siemens Trio scanner while subjects performed the SST, as described in detail in our previous work ([@bb0355], [@bb0370]). Each scan comprised four 10-min runs of the SST. Smokers and caffeine-using subjects were allowed to smoke and drink coffee or other caffeinated beverages until 1 h before the fMRI studies. Functional blood oxygen level dependent (BOLD) signals were acquired with a single-shot gradient echo echo-planar imaging (EPI) sequence, with 32 axial slices parallel to the AC-PC line covering the whole brain, using our published parameters ([@bb0355], [@bb0370]): TR = 2000 ms, TE = 25 ms, bandwidth = 2004 Hz/pixel, flip angle = 85°, FOV = 220 × 220 mm^2^, matrix = 64 × 64, slice thickness = 4 mm and no gap. A high-resolution 3D structural image (MPRAGE; 1 mm resolution) was also obtained for anatomical co-registration.

Functional MRI data was preprocessed with Statistical Parametric Mapping 12 (SPM12) (Wellcome Department of Imaging Neuroscience, University College London, U.K.). Images from the first five TRs at the beginning of each trial were discarded to enable the signal to achieve steady-state equilibrium between RF pulsing and relaxation. Images of each individual subject were first corrected for slice timing, realigned (motion-corrected) ([@bb0010], [@bb0265]). A mean functional image volume was constructed for each subject for each run from the realigned image volumes. The anatomical images (T1-weighted) were co-registered to the mean functional image, and normalized to an MNI (Montreal Neurological Institute) template with affine registration followed by nonlinear transformation using a unified segmentation and registration framework ([@bb0020]). The normalization parameters determined for the anatomical volume were then applied to the corresponding functional image volumes for each subject. In addition, the preprocessing procedures included detrending, and regression of global signal, cerebral spinal fluid, white matter, and six degrees of motion following our optimized pipeline for PSSI estimation ([@bb0505]). Group analyses were performed also using SPM12 on the computed PSSI maps using two sample *t*-tests and multiple regressions, using age as covariate ([@bb0260]). In additional analyses, we examined whether clinical characteristics including alcohol use were associated with the findings on PSSI ([@bb0045], [@bb0580]).

2.5. PSSI {#s0035}
---------

Using methods optimized for fMRI ([@bb0505]), we estimated PSSI β from each FFT-transformed time series S(*f*) as per S(*f*) ∝ *f*^− β^. Power spectrum densities were computed from preprocessed BOLD images on a voxel-wise basis and plotted on a log-log scale. We computed the slope of the linear fit (β) within a frequency window of 0.01--0.25 Hz using least squares fitting; this range of frequency was adopted to exclude low fluctuations drifts (lower limit) and to avoid aliasing (upper limit) following previous experiments on PSSI computation on task data ([@bb0545]). Following our previous work and others\' on the PSSI, we used preprocessed time-series without taking the derivative and reported β to simplify interpretation of correlations and having PSSI represented by positive numbers. Thus, β = 0 represents a power spectrum with maximum entropy (*white noise*), and increasing β represents greater persistence (which can be due either to diminished excitatory inputs or tighter homeostatic constraint over the system via negative feedback ([@bb0485])). PSSI β maps were smoothed with a Gaussian kernel of 6 mm at Full Width at Half Maximum, and were carried to second-level analyses.

3. Results {#s0040}
==========

3.1. Behavioral performance {#s0045}
---------------------------

Behavioral performance is summarized in [Table 2](#t0010){ref-type="table"}. CD showed a decrease in the percentage of successful go trials and in the extent (effect size) of post-signal slowing, as compared to HC individuals. CD showed longer SSRT as compared to HC, but the difference did not reach statistical significance. The latter likely resulted from an under-estimation of the SSRT because the "RT" of a larger number of go error trials could not be considered in the computation of SSRT for CD ([@bb0560]).

3.2. The effects of cocaine misuse and post-signal behavioral adjustment {#s0050}
------------------------------------------------------------------------

Compared to HC, CD presented a significant decrease of PSSI in several frontoparietal structures, including the angular and supramarginal gyri, as well as the inferior and middle frontal gyri ([Fig. 1](#f0005){ref-type="fig"}a and [Table 3](#t0015){ref-type="table"}). We performed a linear regression of PSSI map against the effect size of post-signal slowing (PSS) each in HC and CD. In HC, multiple brain regions in the frontal and parietal cortex showed PSSI in positive correlation with PSS ([Fig. 1](#f0005){ref-type="fig"}b and [Table 4](#t0020){ref-type="table"}). Regions were identified both using a published atlas ([@bb0120]) and with reference to the Automated Anatomical Labeling (AAL) atlas ([@bb0550]). At the same threshold, CD did not show any significant regional association of PSSI to PSS. Notably, subregions of the left inferior frontal gyrus (IFG), left angular gyrus (G), and right supramarginal gyrus (SMG) with reduced PSSI in CD as compared to HC overlapped regions where the PSSI was in positive correlation with PSS in HC ([Fig. 1](#f0005){ref-type="fig"}, insets; [Fig. 2](#f0010){ref-type="fig"}b).

We extracted the PSSI of the left IFG, left AG, and right SMG for all individual CD and HC subjects and confirmed that the PSSI of the left IFG and right SMG were significantly lower in CD than in HC ([Fig. 2](#f0010){ref-type="fig"}a). Further, the differences in slope in the linear regression of the PSS vs. PSSI were significant for both regions ([Fig. 2](#f0010){ref-type="fig"}b; [@bb0595]). The PSSI of the left AG was also significantly lower in CD than in HC (*p* \< 1e − 05); however, the difference in slope in the linear regression of the PSS vs. PSSI was not significant between CD and HC (*p* \> 0.13). The PSSI of none of these ROIs showed a significant correlation with the SSRT (all *p*\'s \> 0.69), go success % (all *p*\'s \> 0.02), stop success % (all *p*\'s \> 0.18), or median go RT (all *p*\'s \> 0.35) for CD or HC.

3.3. Correlation of PSSI with clinical characteristics and other SST performance measures {#s0055}
-----------------------------------------------------------------------------------------

We examined whether the PPSI of the identified clusters was correlated with clinical characteristics of the CD subjects, including BDI score, STAI State/Trait score, CCQ-Brief score, years of alcohol use, days of drinking in the prior month, years of marijuana use, average monthly cocaine use in grams in the prior year, days of cocaine use in the prior month, years of cocaine use, and days abstinent prior to assessment. None of the correlations were significant with correction for multiple corrections (all *p*\'s \> 0.01). The PSSI also did not differ with respect to their smoking status (*p*\'s \> 0.13, main effects and interaction effect, two-way ANOVA).

We also examined whether the PSSI of the identified clusters ([Table 3](#t0015){ref-type="table"}) was correlated with other performance measures of the SST in CD. No clusters showed a significant correlation with the SSRT (all *p*\'s \> 0.37), the go success % (all *p*\'s \> 0.12), the stop success % (all *p*\'s \> 0.30), or the median go RT (all *p*\'s \> 0.13).

3.4. Alcohol use as a potential confound {#s0060}
----------------------------------------

Cocaine addicts showed higher alcohol consumption as compared to controls. Although none of the cocaine dependent participants met the DSM-IV criteria for alcohol dependence --- an exclusion condition for the current study, we examined whether alcohol use was related to PSSI. We performed a linear regression of PSSI against alcohol use measures for individual ROIs, each for CD and HC, and the results showed no significant correlations with years of alcohol use (all *p*\'s \> 0.71 for CD, all *p*\'s \> 0.19 for HC) or days of drinking in the prior month (all *p*\'s \> 0.73 for CD, all *p*\'s \> 0.18 for HC).

3.5. A comparison of GLM based findings and PSSI {#s0065}
------------------------------------------------

We conducted an additional analysis using GLM and queried regional activations to stop versus go trials in correlation with PSS in a linear regression each for HC and CD. At the same statistical threshold, the results showed little overlap with the PSSI maps ([Supplementary Fig. S1](#ec0005){ref-type="supplementary-material"}).

4. Discussion {#s0070}
=============

We observed reduced post-signal slowing (PSS) in the CD as compared to HC groups ([Table 1](#t0005){ref-type="table"}), confirming our previous report of impaired Bayesian learning for cognitive control in cocaine dependence ([@bb0275]). We also observed significant reduction of PSSI in the CD as compared to HC in the left inferior frontal gyrus (IFG) and right supramarginal gyrus (SMG). Compared to HC, CD showed decreased PSS, and the PSSI of the left IFG and right SMG correlated with the extent of PSS in HC but not CD. These findings suggest PSSI as a biomarker of impaired cognitive control in cocaine addiction.

The IFG is part of the ventral attention system, which activates to the detection of a salient, behaviorally relevant target (for review, see ([@bb0105]). Although the bulk of this literature has focused on the role of the right IFG in attention ([@bb0200], [@bb0295]) and its link to response inhibition ([@bb0075], [@bb0115], [@bb0130]), studies have implicated the left IFG in attentional processes including responses to mismatch negativity ([@bb0225]), as well as to repetition priming during word recognition ([@bb0470], [@bb0535]) and sound tone identification ([@bb0015]). The left IFG responds to the resolution of semantic conflicts between linguistic inputs ([@bb0585]). In a perceptual decision task, activations of the left IFG varied with response bias to changing motivational context, suggesting a role in flexible behavioral control ([@bb0495]). Studies with transcranial magnetic stimulation also demonstrated an interaction between the left IFG and pre-supplementary motor area to facilitate response inhibition ([@bb0465]). The left IFG responds to inhibition of proactive interference ([@bb0155], [@bb0285]). Fatigue in interference control resulted in decreased activity in the left IFG and other cortical and subcortical structures ([@bb0480]). Further, patients with left IFC lesions were compromised in inhibitory control in the stop signal task ([@bb0530]). In studies of clinical populations, hypoactivation of the left IFG was noted in problem video gamers during Stroop interference ([@bb0405]). Compared to non-smokers, smokers demonstrated decreased activity in the left IFG in link with impaired performance on the go/no-go task ([@bb0410]). In reappraising evoked emotions, older participants demonstrated reduced activation of the left IFG, as compared to young adults ([@bb0570]). Together, these studies support a role of the left IFG in attention and cognitive control. The current findings demonstrated PSSI as a neural correlate of post-signal behavioral adjustment and diminished PSSI in the left IFG as an additional neural marker of impaired control in cocaine addicts.

As part of the inferior parietal lobule, the SMG also partakes in the ventral attentional network ([@bb0105]). The SMG is responsible for the attentional component of episodic memory ([@bb0070]) and through functional connectivity with the somatomotor cortex, supports attentional mechanisms that underlie visuomotor learning ([@bb0425]). The right but not left SMG responds to saccadic eye movements made to a peripheral visual target ([@bb0475]) and to "inhibition of return", a mechanism that prioritizes attention to new, yet-to-be-explored spatial locations ([@bb0310], [@bb0350], [@bb0325], [@bb0330]). In cognitive control, the right SMG responds to set shifting contingent on outcome evaluation ([@bb0245]). Proactive emotional control engages multiple brain regions including the pre-supplementary motor area and right SMG ([@bb0555]). The supplementary eye field, anterior cingulate cortex, inferior frontal gyri and right SMG respond to inhibition of saccadic eye movements in an oculomotor go/nogo task ([@bb0055], [@bb0060], [@bb0140]). The cortical thickness and white matter integrity of the right inferior parietal regions are linked to the capacity of attentional orienting in a visuospatial task ([@bb0590]). In clinical populations, voxel-based morphometry showed lower gray matter volumes in the striatum and right SMG in cocaine dependent patients, as compared to controls ([@bb0025]). Chronic methamphetamine users also demonstrated loss of gray matter volume in the right SMG ([@bb0195]). Frontoparietal functional connectivity involving the right SMG was decreased in adolescents at risk for dysfunctional control and depression ([@bb0095]). Together, these findings support a role of the right SMG in orienting attention to external stimuli in support of motor decision making in a variety of behavioral contexts. These processes, including post-signal slowing in the SST, are likely compromised in chronic cocaine users and, as the current study shows, may be reflected in altered PSSI as a dynamics measure of cerebral cortical activity.

In addition to the IFG and SMG, we observed significant reduction of PSSI values in several other fronto-parietal regions in CD as compared to HC. This suggests that the fMRI signals overall are more random in these regions. Considering the equivalence between auto-correlation and PSSI measures ([@bb0210], [@bb0460]), the reduction in PSSI indicates weaker autocorrelation/persistence in these regions. In line with previous reports of PSSI deviations from the neurotypical range in other neurological and psychiatric disorders ([@bb0305], [@bb0435], [@bb0455], [@bb0460], [@bb0490], [@bb0545]), the current study is the first to report reduced PSSI in cocaine addicts and its association with deficits in cognitive control.

By comparing findings from GLM and PSSI analyses, we observed little overlap between the maps ([Supplementary Fig. S1](#ec0005){ref-type="supplementary-material"}). This finding may suggest that PSSI captures changes in circuit dynamics that elude GLM analyses, with the latter characterizing mean-based brain responses and PSSI describing altered second order statistics of fMRI signals ([@bb0205]). However, this observation also calls for a broader question regarding the relationship between various neural measures investigators have used to quantify cerebral structural integrity and highlight regional activations in health and illness. For instance, we examined whole-brain morphometry and fractional amplitude of low-frequency fluctuation (fALFF) of fMRI signals and noted similar changes in the prefrontal and frontal cortices in fALFF and gray matter density during healthy aging ([@bb0250]) but not in cocaine addicts ([@bb0280]). Further, these findings do not mirror age-related changes identified for various GLM contrasts, including response inhibition, error processing, and risk taking, from the stop signal task ([@bb0260]) or age-related changes in PSSI (unpublished observations). More studies are clearly needed to provide insight to this important issue.

Finally, although we employed a previously optimized preprocessing pipeline for PSSI estimation in fMRI data ([@bb0505]), aiming to remove measurement and physiological noises, we are not able to rule out the possibility of PSSI changes due to the effects of chronic cocaine use on the vascular system. Further studies to include imaging of cerebral perfusion are necessary to dissociate neural from vascular consequences of cocaine abuse.

5. Conclusions {#s0075}
==============

Taken together, the current findings suggest altered PSSI as a useful neural marker for cocaine misuse and impaired cognitive control. Along with our previous work ([@bb0490], [@bb0505], [@bb0545]), these new findings support the utility of PSSI in delineating the complex neural circuitry of various psychopathologies. Future work is needed to examine what is driving the decreased PPSI in the IFG and SMG by delineating the connectivity between regions in the frontoparietal network ([@bb0485]).

The following is the supplementary data related to this article.Fig. S1(a) GLM contrast map (Stop \> Go) correlated with PSS for HC. (b) PSSI map correlated with PSS for HC. (c) GLM contrast map (Stop \> Go) correlated with PSS for CD. (d) PSSI map correlated with PSS for CD. Hot color: positive correlation, cold color: negative correlation. *p* \< 0.05, corrected AlphaSim threshold.Fig. S1
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![(a) Regions showing reduced PSSI in CD as compared to HC; two sample *t*-test with age as covariate. No brain regions showed increased PSSI in CD as compared to HC at the same threshold. Clusters that survived the corrected extent threshold are shown in [Table 3](#t0015){ref-type="table"}. (b) Regions with PSSI in linear correlation with post-signal slowing (PSS) in the HC; multiple regression with PSS and age as covariates. *p* \< 0.05, corrected AlphaSim threshold. Clusters that survived the corrected extent threshold are shown in [Table 4](#t0020){ref-type="table"}. The inset each highlights the overlap in the left inferior frontal gyrus (IFG), left angular gyrus (AG) and right supramarginal gyrus (SMG) between these two group analyses.](gr1){#f0005}

![(a) Compared to HC, CD showed decreased PSSI in the left inferior frontal gyrus (IFG) and right supramarginal gyrus (SMG) (two sample *t*-test); (b) PSSI increased in association with post-signal slowing in the IFG (*r* = 0.31, *p* = 0.003) and SMG (*r* = 0.35, *p* = 0.001) in HC but not CD. A direct test shows a significant difference in slope of the linear regression in both cases ([@bb0595]).](gr2){#f0010}

###### 

Demographics of cocaine dependent (CD) and healthy control (HC) subjects.

Table 1

  Subject characteristic                         CD (*n* = 75)   HC (*n* = 88)   *p*-Value
  ---------------------------------------------- --------------- --------------- ------------------------------------------
  Age (years)                                    39.9 ± 7.6      38.7 ± 10.9     0.43[a](#tf0005){ref-type="table-fn"}
  Gender (M/F)                                   50/25           49/39           0.15[b](#tf0010){ref-type="table-fn"}
  Beck Depression Inventory (BDI)                12.2 ± 9.2      N/A             N/A
  STAI State                                     37.6 ± 11.0     N/A             N/A
  STAI Trait                                     41.7 ± 11.7     N/A             N/A
  CCQ-Brief                                      20.8 ± 8.3      N/A             N/A
  Current smoker (yes/no)                        59/16           31/57           1e − 12[b](#tf0010){ref-type="table-fn"}
  Years of alcohol use                           16.1 ± 9.3      14.9 ± 14.3     0.57[a](#tf0005){ref-type="table-fn"}
  Days of drinking (prior month)                 12.7 ± 7.5      3.4 ± 5.3       1e − 16[a](#tf0005){ref-type="table-fn"}
  Years of marijuana use                         10.0 ± 4.1      N/A             N/A
  Average monthly cocaine use (gm), prior year   18.8 ± 27.3     N/A             N/A
  Days of cocaine use (prior month)              15.3 ± 8.7      N/A             N/A
  Years of cocaine use                           18.0 ± 8.2      N/A             N/A
  Days abstinent prior to assessment             18.0 ± 5.9      N/A             N/A

Note: values are mean ± S.D.

Two-tailed two-sample *t*-test.

χ^2^ test.

###### 

Performance in the stop signal task.

Table 2

                                               SSRT (ms)   Median go RT (ms)   %go          %stop        PSS (effect size)
  -------------------------------------------- ----------- ------------------- ------------ ------------ -------------------
  CD (*n* = 75)                                230 ± 50    594 ± 99            95.9 ± 1.4   52.4 ± 3.5   1.37 ± 2.10
  HC (*n* = 88)                                222 ± 45    624 ± 104           96.6 ± 1.9   52.8 ± 3.3   2.07 ± 1.98
  *p*-Value[a](#tf0015){ref-type="table-fn"}   0.31        0.06                0.01         0.40         0.03

Note: All values are mean ± standard deviation; CD: individuals with cocaine dependence; HC: healthy controls; SSRT: stop signal reaction time; RT: reaction time; %go: percentage of go response trials; PSS: post-signal slowing.

*p*-Value based on 2-tailed 2-sample *t*-test.

###### 

Regions with reduced PSSI in CD (*n* = 75) as compared to HC (*n* = 88); *t*-test with age as covariate, *p* \< 0.05, corrected AlphaSim threshold. Cluster k \> 100. All peak voxels 8 mm apart are identified.

Table 3

  Volume voxels (k)   Peak voxel   MNI coordinate   Side   Identified brain region                                                               
  ------------------- ------------ ---------------- ------ ------------------------- ----------------------------------------------------------- ----------------------------------------------------------
  951                 5.76         48               − 61   50                        R                                                           Angular gyrus[a](#tf0020){ref-type="table-fn"}
  5.20                57           − 58             41     R                         Inferior parietal cortex[a](#tf0020){ref-type="table-fn"}   
  4.56                48           − 43             44     R                         Supramarginal gyrus[a](#tf0020){ref-type="table-fn"}        
  947                 5.47         − 36             − 76   47                        L                                                           Middle occipital cortex[a](#tf0020){ref-type="table-fn"}
  5.46                − 54         − 43             47     L                         Supramarginal gyrus[a](#tf0020){ref-type="table-fn"}        
  4.76                − 45         − 73             38     L                         Middle occipital cortex[a](#tf0020){ref-type="table-fn"}    
  114                 3.70         − 45             47     8                         L                                                           Inferior frontal cortex
  2.95                − 45         38               23     L                         Inferior frontal gyrus                                      
  2.91                − 51         26               29     L                         Inferior frontal gyrus                                      
  136                 3.54         42               50     − 1                       R                                                           Lateral orbitofrontal cortex
  3.49                36           59               8      R                         Lateral frontal cortex                                      

Indicates clusters significant at *p* \< 0.05, FWE corrected.

###### 

Regions with PSSI in positive correlation with the extent of post-signal slowing (PSS) in HC; multiple regression with age as a covariate, *p* \< 0.05, corrected AlphaSim threshold. Cluster k \> 100. All peak voxels 8 mm apart are identified. No clusters met the threshold in CD.

Table 4

  Volume voxels (k)   Peak voxel   MNI coordinate   Side   Identified brain region                                 
  ------------------- ------------ ---------------- ------ ------------------------- ----------------------------- ---------------------------------------
  109                 4.16         − 54             23     29                        L                             Inferior frontal gyrus
  3.62                − 48         32               23     L                         Inferior frontal gyrus        
  618                 4.06         63               − 61   26                        R                             Supramarginal/superior temporal gyrus
  3.71                24           − 85             41     R                         Superior occipital gyrus      
  111                 3.73         − 60             − 46   44                        L                             Angular gyrus
  3.71                − 66         − 40             38     L                         Angular gyrus                 
  155                 3.64         36               − 64   − 19                      R                             Fusiform gyrus
  3.24                54           − 58             − 16   R                         Inferior temporal gyrus       
  3.17                45           − 49             − 13   R                         Inferior temporal gyrus       
  213                 3.60         63               2      11                        R                             Rolandic operculum
  3.05                60           − 7              38     R                         Postcentral gyrus             
  2.72                54           − 7              26     R                         Postcentral gyrus             
  127                 3.42         − 9              53     − 16                      L                             Rectus gyrus
  3.33                − 9          53               − 4    L                         Medial orbitofrontal cortex   
  3.12                3            59               − 19   R                         Rectus gyrus                  
